Partnering to offer Gusev Ester Hydrogenation Catalysts

We've announced the successful scale-up and commercial availability of a novel Gusev catalyst for ester hydrogenation. Using licensed technology developed by GreenCentre Canada, the catalyst combines high activity with high chemoselectivity that could revolutionise industrial applications of ester hydrogenation.

 

The technology, which was originally conceived and developed in the laboratories of Professor Dmitri Gusev of Wilfrid Laurier University, was exclusively licensed from GreenCentre Canada, a provider of intellectual property services to support the development of chemistry-driven activities, to JM in 2016. Following this agreement, JM has scaled the manufacturing process of the Gusev catalyst, known as Ru-SNS, that shows exceptional activity for the important chemical transformation known as ester hydrogenation.

Ester hydrogenation is an essential transformation in the chemical industry used to form primary alcohols. It is widely used in the manufacture of a variety of commercial products including pharmaceuticals, detergents, cosmetics, flavours and fragrances.

Compared with existing industrial processes, the Gusev catalyst offers exceptional reactivity and improved selectivity, as well as possessing a higher tolerance of challenging functional groups. Reactions using this catalyst are also safer, owing to the milder operating conditions, and produce less environmental waste. The advantages offered by this catalytic process have the potential to greatly improve the economic and environmental performance of many large-scale commercial chemical processes.


“As a leader in the development and application of catalyst technologies, JM is delighted to add this new technology to its portfolio of leading capabilities. We believe that this new method of ester reduction will enable the development of many novel, elegant and sustainable processes.”
Gerard Compagnoni, General Manager, Johnson Matthey

Media enquiries

For more information regarding JM, contact:

Kate Whelan
Notch Communications
+46(0) 70 238 11 49 / +44(0) 161 457 7230
Email

Find out more

Markets

Pharmaceutical and medical

Read more
Products and services

Pharmaceutical products and services

Explore